Effects of concurrent transcranial direct current stimulation on human motor skill learning: A systematic review and Bayesian meta-analysis.

Behav Brain ResJul 16, 2026 (epub)
Clinical ResearchPhysical Medicine & RehabilitationNeurology

August Lomholt Kvistad, Maria Isbrandt Gad, Lasse Jespersen et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and Bayesian meta-analysis examined the effects of concurrent transcranial direct current stimulation (tDCS) on motor skill learning across 73 studies. The analysis revealed that tDCS applied during motor practice significantly improved speed and accuracy, particularly with multiple practice sessions. The findings suggest that tDCS can enhance motor learning processes.

Key findings

  • tDCS targeting the motor cortex improved speed and accuracy in motor skill learning.
  • Smaller effects were observed for skill retention between sessions.
  • Multiple practice sessions with tDCS showed more favorable outcomes.
  • The analysis included 73 studies with a focus on tDCS effects.

Why it matters

Understanding the impact of tDCS on motor skill learning can inform rehabilitation strategies, potentially enhancing recovery and functional abilities in patients undergoing motor training.

Source

PubMed · PMID 42463027

Published in Behav Brain Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Physical Medicine & Rehabilitation

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.